{"Symbol": "SOLV", "AssetType": "Common Stock", "Name": "Solventum Corp.", "Description": "Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. The company is headquartered in Saint Paul, Minnesota.", "CIK": "1964738", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "MEDICAL INSTRUMENTS & SUPPLIES", "Address": "3M CENTER, MAPLEWOOD, MN, UNITED STATES, 55144-1000", "OfficialSite": "https://www.solventum.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "13103963000", "EBITDA": "1259000000", "PERatio": "8.67", "PEGRatio": "1.342", "BookValue": "28.75", "DividendPerShare": "None", "DividendYield": "None", "EPS": "8.71", "RevenuePerShareTTM": "48.32", "ProfitMargin": "0.181", "OperatingMarginTTM": "0.0782", "ReturnOnAssetsTTM": "0.0321", "ReturnOnEquityTTM": "0.373", "RevenueTTM": "8402000000", "GrossProfitTTM": "4571000000", "DilutedEPSTTM": "8.71", "QuarterlyEarningsGrowthYOY": "9.31", "QuarterlyRevenueGrowthYOY": "0.007", "AnalystTargetPrice": "89.25", "AnalystRatingStrongBuy": "2", "AnalystRatingBuy": "5", "AnalystRatingHold": "5", "AnalystRatingSell": "1", "AnalystRatingStrongSell": "1", "TrailingPE": "8.67", "ForwardPE": "11.9", "PriceToSalesRatioTTM": "1.56", "PriceToBookRatio": "2.628", "EVToRevenue": "1.976", "EVToEBITDA": "6.4", "Beta": "None", "52WeekHigh": "88.2", "52WeekLow": "60.7", "50DayMovingAverage": "80.37", "200DayMovingAverage": "75.13", "SharesOutstanding": "173448000", "SharesFloat": "147340000", "PercentInsiders": "14.958", "PercentInstitutions": "75.128", "DividendDate": "None", "ExDividendDate": "None"}